title: Asparagus P(R) cannot compete with first-line diuretics in lowering the blood pressure in treatment-requiring antihypertensives.
abstract: A six week clinical surveillance of 163 patients receiving maximally tolerable doses of Asparagus P((R)), a proprietary mixture pulversied dried asparagus root and parsley leaf, has not indicated any clinically useful antihypertensive effect. The profile of adverse events (with 7 patients leaving the surveillance early because of renally related complaints) contraindicates its use in hypertension or to promote flushing of the efferent tract in rental inflammatory conditions or urolithiasis.
authors.forename: Sigrun
authors.initials: S
authors.lastname: Chrubasik
authors.forename: Conrad
authors.initials: C
authors.lastname: Droste
authors.forename: Andy
authors.initials: A
authors.lastname: Black
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D027761:Asparagus Plant; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004232:Diuretics / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008517:Phytotherapy / Q000009:adverse effects*
chemical_list: D000959:Antihypertensive Agents; D004232:Diuretics